NCT01268735

Brief Summary

Purpose To try to establish whether lid-parallel conjunctival folds (LIPCOF) can be influenced by increased lubrication with rewetting and lubricating eyedrops containing hydroxypropyl-guar, which has proven lubricating effect. Methods During summer and fall of 2009, 16 ophthalmologists from various regions of Croatia investigated the effect of topical therapy with lubricating eyedrops on the signs and symptoms of dry eye, with the special emphasis on lid-parallel conjunctival folds (LIPCOF). 229 patients were enrolled in the study. Results After 14 days of therapy with lubricating eyedrops containing hydroxypropyl-guar, statistically significant reduction of LIPCOF grade was observed, as well as the reduction of symptoms and other signs of dysfunctional tear syndrome (TBUT, Schirmer test, conjunctival hyperemia). Conclusion Results of this study have shown positive influence of lubricating eyedrops containing hydroxypropyl-guar on signs and symptoms of dysfunctional tear syndrome even after only 14 days of treatment. It is of particular interest that LIPCOF grade was statistically significantly decreased, pointing at increased friction and decreased ocular surface lubrication as possible causes of its appearance. Having this in mind, every clinician involved in dysfunctional tear syndrome treatment must also think about lubrication as integral part of treating this condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Apr 2009

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 31, 2010

Completed
Last Updated

December 31, 2010

Status Verified

December 1, 2010

Enrollment Period

5 months

First QC Date

December 30, 2010

Last Update Submit

December 30, 2010

Conditions

Keywords

Dysfunctional Tear SyndromeDry EyeLIPCOFHydroxypropyl-guar

Outcome Measures

Primary Outcomes (1)

  • Lid-parallel conjunctival folds (LIPCOF)

    The effect of topical therapy with lubricating eyedrops on lid-parallel conjunctival folds (LIPCOF).

    14 days

Secondary Outcomes (1)

  • Signs and symptoms of dry eye

    14 days

Study Arms (1)

Lubricating eyedrops containing HP-guar

EXPERIMENTAL
Drug: Lubricating eyedrops containing hydroxypropyl-guar

Interventions

Eyedrops BID

Also known as: Systane lubricating eyedrops, ALCON
Lubricating eyedrops containing HP-guar

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ocular foreign body sensation, burning or stinging, complaints more pronounced in winter, windy conditions, during computer work, being bilateral, of the duration longer than three months, visual acuity fluctuations depending on blinking after longer reading or computer work, and tearing in cold weather, in the morning, after longer reading or computer work. Patients were also asked whether the symptoms were more pronounced in the morning or evening. The main enrollment criterion was the score of the above listed symptoms 15 or higher.

You may not qualify if:

  • Pregnant women, children, chronic eye patients on continuous topical therapy during previous month (i.e.glaucoma) and patients suffering from any acute eye disease and therefore on topical or systemic therapy in the previous month were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagreb University Hospital Eye Department

Zagreb, HR-10000, Croatia

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Igor Petricek, MD

    Zagreb University Hospital Eye Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 30, 2010

First Posted

December 31, 2010

Study Start

April 1, 2009

Primary Completion

September 1, 2009

Study Completion

February 1, 2010

Last Updated

December 31, 2010

Record last verified: 2010-12

Locations